Across TCGA pan-cancer cohorts, MIR3611 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MIR3611’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR3611 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR3611 is over-expressed in tumor.
STAD are the cancer types where MIR3611 tumor–normal differential expression is most reproducible.